Dr. Latha Kiran Krishna Rajendran
Dr. Latha Kiran Krishna Rajendran is an Indian physician-scientist, clinical researcher, and healthcare innovator recognized for her interdisciplinary contributions at the intersection of clinical medicine, artificial intelligence, predictive healthcare systems, and precision oncology. With over seven years of frontline clinical experience and an expanding international academic presence, she has established herself as a physician integrating translational research, evidence-based medicine, and advanced computational intelligence to address complex healthcare challenges.
Currently serving as a General Practitioner and Consultant at ELOVA Hospitals, Dr. Latha Kiran has managed a high-volume clinical practice involving thousands of patients across diverse medical specialties, including internal medicine, emergency care, women’s health, maternal medicine, pediatrics, geriatric care, and chronic disease management. Her clinical leadership encompasses acute patient stabilization, preventive healthcare, evidence-based treatment protocols, multidisciplinary patient management, and healthcare quality improvement in fast-paced clinical environments.
She is widely recognized for her patient-centered approach, combining compassionate clinical care with precision-driven medical decision-making. Over the course of her medical career, she has handled complex emergency cases, managed high-risk maternal and pediatric patients, and contributed significantly to improving long-term patient outcomes through preventive and chronic disease management strategies. Her expertise also extends to clinical procedures, healthcare operations, aesthetic and dermatological interventions, and implementation of standardized clinical protocols aimed at improving healthcare efficiency and patient safety.
During the COVID-19 pandemic, Dr. Latha Kiran served on the frontline as a Medical Officer, actively participating in public health response initiatives, vaccination programs, infectious disease management, community health campaigns, and large-scale preventive healthcare programs. Her contributions during this period reflected her commitment to public health leadership, population-based healthcare delivery, and evidence-based medical practice under high-pressure clinical settings.
Beyond clinical practice, Dr. Latha Kiran has gained recognition for her scholarly contributions in oncology, predictive medicine, and AI-driven healthcare innovation. Her research focuses on developing intelligent healthcare frameworks that integrate artificial intelligence, radiology, genomics, predictive analytics, and digital health technologies to improve early disease detection, treatment personalization, and precision oncology outcomes. Her work spans emerging domains such as cancer immunotherapy, theranostics, radiogenomics, nanomedicine, machine learning–based clinical decision systems, predictive cancer modeling, and explainable artificial intelligence in medicine.
She has authored multiple peer-reviewed scholarly publications in internationally indexed journals, including Scopus-indexed Q1 and Q3 journals, addressing advanced topics in oncology, translational medicine, pharmacogenomics, immunotherapy resistance, AI-assisted cancer prediction, and computational healthcare systems. Her research contributions demonstrate a consistent commitment to advancing next-generation precision medicine through clinically relevant and technologically scalable innovations.
In addition to her academic publications, Dr. Latha Kiran has contributed to scientific advancement through peer review activities, conference leadership, invited speaking engagements, and interdisciplinary collaborations. She has served as a peer reviewer for international journals and global conferences in artificial intelligence, healthcare analytics, and predictive medicine. She has also participated as a session chair and invited speaker at international academic conferences focused on AI-powered oncology, early cancer detection, and digital healthcare transformation.
Her professional affiliations include internationally respected organizations such as the American Society of Clinical Oncology, American Public Health Association, Sigma Xi, and IEEE Engineering in Medicine and Biology Society, reflecting her active engagement in global scientific, clinical, and technological advancement communities.
Driven by a vision to redefine the future of healthcare, Dr. Latha Kiran is committed to transforming medicine from reactive disease management toward predictive, preventive, and precision-driven healthcare systems powered by intelligent technologies. Her professional motto centers on combining compassionate patient care with scientific innovation, with the goal of making advanced, data-driven, and personalized healthcare accessible, scalable, and impactful for future generations. By uniquely bridging real-world clinical medicine with translational research and computational intelligence, she represents an emerging generation of physician-researchers contributing to the future of AI-enabled healthcare, precision oncology, and next-generation medical intelligence systems.